LEUCID BIO
Leucid Bio is a pioneering biotech company developing cell therapies for refractory cancers, especially solid tumors. Leucid was founded to translate 20 years of King's College London (King's) research in the CAR-T field and is led by a highly experienced management team with both scientific and commercial expertise. As part of Leucid's ongoing relationship with King's, it benefits from exclusive access to and resources from the deep scientific, clinical, and manufacturing expertise of Dr. Maher and his academic team of immuno-oncology experts.
LEUCID BIO
Social Links:
Industry:
Biotechnology
Founded:
2014-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.leucid.com
Total Employee:
11+
Status:
Active
Total Funding:
11.5 M GBP
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Wix Hosted
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Epidarex Capital
Epidarex Capital investment in Series A - Leucid Bio
2invest
2invest investment in Series A - Leucid Bio
Sofinnova Partners
Sofinnova Partners investment in Series A - Leucid Bio
Vulpes Investment Management Pte Ltd
Vulpes Investment Management Pte Ltd investment in Series A - Leucid Bio
British Business Bank
British Business Bank investment in Series A - Leucid Bio
Official Site Inspections
http://www.leucid.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
